Inflammatory markers in acute exacerbations of obstructive pulmonary disease: Predictive value in relation to smoking history

Respiratory Medicine

Volumn 93, Issue 10, 1999, Pages 744-751

  Dahlen I ^a,c   Janson, C ^a   Bjornsson E ^a   Stalenheim G ^a   Peterson, C G B ^b   Venge, P ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b PFIZER INC   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; INTERLEUKIN 5; MYELOPEROXIDASE; PEROXIDASE; PREDNISOLONE; SALBUTAMOL; STEROID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; EMERGENCY TREATMENT; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; NEUTROPHIL; PRIORITY JOURNAL; SMOKING; SPUTUM; URINALYSIS;

EID: 0032756752     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90043-4     Document Type: Article

References (34)

1. Djukanovic R, Wilson JW, Britten KM et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871.
2. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
3. Lacoste JY, Bousquet J, Chanez P et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92: 537-548.
4. Martin TR, Raghu G, Maunder RJ, Springmeyer SC. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis 1985; 132: 254-260.
5. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
6. Ruse GC, Ahlstedt S, Larsson S et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronch ial lavage fluid. Thorax 1995; 50: 360-365.
7. Linden M, Rasmussen JB, Piitulainen E et al. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148: 1226-1232.
8. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26: 766-774.
9. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-1652.
10. Lee MH, Lee JH, Park CH, Ahn YM, Koh YY. Serum eosinophil cationic protein levels and bronchodilator responses at acute asthma exacerbation. Ann Allergy Asthma Immunol 1997; 79: 363-369.
11. Janson C, Herala M. Blood eosinophil count as risk factor for relapse in acute asthma. Respir Med 1992; 86: 101-104.
12. Pedersen B, Dahl R, Karlström R, Peterson CG, Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Clin Care Med 1996; 153: 1519-1529.
13. European Community for Coal and Steel. Standardized lung function testing. Clin Respir Physiol 1983; 19: S22-S27.
14. Carlson MG, Peterson CG, Venge P. Human eosinophil peroxidase: purification and characterization. J Immunol 1985; 134: 1875-1879.
15. Xu SY, Petersson CG, Carlson M, Venge P. The development of an assay for human neutrophil lipocalin (HNL)-to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994; 171: 245-252.
16. Chanez P, Vignola AM, ÓShaugnessy T et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Resp Crit Care Med 1997; 155: 1529-1534.
17. Pizzichini E, Pizzichini MM, Gibson P et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158: 1511-1517.
18. Keatings V, Jatakonon A, Worsdell Y, Barnes P. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
19. Mensinga TT, Scheuten JP, Weiss ST, Van der Lende R. Relationship of skin test reactivity and eosinophilia to level of pulmonary function in a community-based population study. Am Rev Respir Dis 1992; 146: 638-643.
20. Martin LB, Kita H, Leiferman KM, Gleich GJ. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996; 109: 207-215.
21. Synek M, Beasley R, Frew AJ et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154: 224-230.
22. Venge P. Eosinophil activity in bronchial asthma. Allergy Proc 1994; 15: 139-141.
23. . Holgate ST, Roche WR, Church MK. The role of the eosinophil in asthma. Am Rev Respir Dis 1991; 143: S66-S70.
24. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997; 113: 196-199.
25. Robinson DS, Durham SR, Kay AB. Cytokines. 3. Cytokines in asthma. Thorax 1993; 48: 845-853.
26. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness. Respir Med 1996; 90: 39-46.
27. Kristjansson S, Strannegård IL, Strannegård O, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996; 97: 1179-1187.
28. Lugosi E, Halmerbauer G, Frischer T, Koller DY. Urinary eosinophil protein X in relation to disease activity in childhood asthma. Allergy 1997; 52: 584-588.
29. Schoeffel R, Andersson S, Altouynan R. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulized solutions of distilled water and saline. BMJ 1981; 63: 459-471.
30. Pizzichini MM, Popov TA, Efthimiadis A et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 866-869.
31. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147: 1126-1131.
32. Pizzichini E, Pizzichini MM, Efthimiadis A et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
33. Grebski E, Graf C, Hinz G, Wuthrich B, Medici TC. Eosinophil cationic protein in sputum is dependent on temperature and time. Eur Resp J 1998; 11: 734-737.
34. Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Björksten F, Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 1997; 8: 45-50.